36C24223Q0707.pdf

Special Notice

*= Required Field Special Notice

SUBJECT* Intent To Sole Source - LU177 Vipivotide Tetra (Pluvicto)

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE* 12203

SOLICITATION NUMBER* 36C24223Q0707

ARCHIVE 15 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS N

PRODUCT SERVICE CODE* 6505

NAICS CODE* 325412

CONTRACTING OFFICE ADDRESS

Department of Veterans Affairs Samuel S. Stratton VA Medical Center 20 Madison Avenue Ext.)

Albany NY 12203

POINT OF CONTACT* Contract Specialist Myra F. Green Myra.Green2@va.gov

ADDITIONAL INFORMATION

AGENCY’S URL https://vaww.visn2.va.gov/albany/index.asp URL DESCRIPTION New York/New Jersey VA Health Care Network AGENCY CONTACT’S EMAIL ADDRESS Myra.Green2@va.gov EMAIL DESCRIPTION Contract Specialist /POC

DESCRIPTION

The Network Contracting Office (NCO) 2, Department of Veterans Affairs intends to award a firm-fixed-price sole source contract with Advanced Accelerator Applications USA, Inc., a large business, for the purchase of LU177 Vipivotide Tetra (Pluvicto) delivery/service for

VA Western New York Healthcare System Buffalo VAMC Nuclear Medicine 3495 Bailey Avenue Buffalo, NY 14215

This sole source determination is in accordance with FAR 8.405-6(a)(1)(B), Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. Advanced Accelerator Applications USA, Inc. is the only known authorized supplier for LU177 Vipivotide Tetra (Pluvicto).

The North American Industry Classification System (NAICS) code for this procurement is 325412 and the size standard is 1,250 employees.

Statement of Need: The New York/New Jersey Healthcare System Veterans Integrated Service Network (VISN) 2, in support of VA Buffalo Medical Center has a requirement for LU177 Vipivotide Tetra (Pluvicto) delivery/service. Capable contractors must primarily be engaged in the business of radiopharmaceutical therapy resell in a Medical Center environment.

Federal Supply Schedule: If your firm provides the radiopharmaceutical therapy on GSA Federal Supply Schedule, please provide applicable contract number and identify which supply/ service are applicable to that FSS contract.

Technical abilities:

• Contractor must be either the manufacturer or fully licensed, authorized and have selling permission for the reagent kits.

• Contractor shall be FDA certified

No solicitation package will be issued at this time. This notice of intent is not a request for competitive quotes; however, interested parties may identify their interest and technical capability to respond to this requirement. Interested vendors that can meet this requirement, should identify their interest and capability, and respond to this notice by 2:00 PM EST on May 12, 2023. Interested vendors must send a capability statement, no more than one page in length; to include Company Name, UEI Number, Socioeconomic Category, brief description of your business entities capability to provide these items. All information shall be provided at no cost or obligation to the Government.